These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37440017)

  • 1. Repurposing Drugs for Treatment of Age-Related Macular Degeneration.
    Francisco SG; Rowan S
    Adv Exp Med Biol; 2023; 1415():73-77. PubMed ID: 37440017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposing medications for treatment of age-related macular degeneration: Insights from novel approaches to data mining.
    Moir J; Aggarwal S; Skondra D
    Exp Biol Med (Maywood); 2023 May; 248(9):798-810. PubMed ID: 37452694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of fluoxetine as a direct NLRP3 inhibitor to treat atrophic macular degeneration.
    Ambati M; Apicella I; Wang SB; Narendran S; Leung H; Pereira F; Nagasaka Y; Huang P; Varshney A; Baker KL; Marion KM; Shadmehr M; Stains CI; Werner BC; Sadda SR; Taylor EW; Sutton SS; Magagnoli J; Gelfand BD
    Proc Natl Acad Sci U S A; 2021 Oct; 118(41):. PubMed ID: 34620711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PU-91 drug rescues human age-related macular degeneration RPE cells; implications for AMD therapeutics.
    Nashine S; Subramaniam SR; Chwa M; Nesburn A; Kuppermann BD; Federoff H; Kenney MC
    Aging (Albany NY); 2019 Sep; 11(17):6691-6713. PubMed ID: 31477635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular Degeneration.
    Brilliant MH; Vaziri K; Connor TB; Schwartz SG; Carroll JJ; McCarty CA; Schrodi SJ; Hebbring SJ; Kishor KS; Flynn HW; Moshfeghi AA; Moshfeghi DM; Fini ME; McKay BS
    Am J Med; 2016 Mar; 129(3):292-8. PubMed ID: 26524704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Metformin and Other Diabetes Medication Use and the Development of New-Onset Dry Age-Related Macular Degeneration: A Case-Control Study.
    Kaufmann GT; Hyman MJ; Gonnah R; Hariprasad S; Skondra D
    Invest Ophthalmol Vis Sci; 2023 Aug; 64(11):22. PubMed ID: 37589984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Oral Metformin Use and the Development of Age-Related Macular Degeneration in Diabetic Patients: A Systematic Review and Meta-Analysis.
    Liang KH; Chen CH; Tsai HR; Chang CY; Chen TL; Hsu WC
    Invest Ophthalmol Vis Sci; 2022 Dec; 63(13):10. PubMed ID: 36484633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facilitating Drug Repurposing-Using Databases for Drug Discovery in AMD.
    Magagnoli J; Sutton SS; Ambati J
    JAMA Ophthalmol; 2024 Aug; 142(8):759-760. PubMed ID: 38990521
    [No Abstract]   [Full Text] [Related]  

  • 9. Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality.
    Xu H; Aldrich MC; Chen Q; Liu H; Peterson NB; Dai Q; Levy M; Shah A; Han X; Ruan X; Jiang M; Li Y; Julien JS; Warner J; Friedman C; Roden DM; Denny JC
    J Am Med Inform Assoc; 2015 Jan; 22(1):179-91. PubMed ID: 25053577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between metformin use and the risk of age-related macular degeneration in patients with type 2 diabetes: a retrospective study.
    Jiang J; Chen Y; Zhang H; Yuan W; Zhao T; Wang N; Fan G; Zheng D; Wang Z
    BMJ Open; 2022 Apr; 12(4):e054420. PubMed ID: 35473747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Metformin Use With Age-Related Macular Degeneration: A Case-Control Study.
    Blitzer AL; Ham SA; Colby KA; Skondra D
    JAMA Ophthalmol; 2021 Mar; 139(3):302-309. PubMed ID: 33475696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repurposing an orally available drug for the treatment of geographic atrophy.
    Ahmed CM; Biswal MR; Li H; Han P; Ildefonso CJ; Lewin AS
    Mol Vis; 2016; 22():294-310. PubMed ID: 27110092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risuteganib-a novel integrin inhibitor for the treatment of non-exudative (dry) age-related macular degeneration and diabetic macular edema.
    Shaw LT; Mackin A; Shah R; Jain S; Jain P; Nayak R; Hariprasad SM
    Expert Opin Investig Drugs; 2020 Jun; 29(6):547-554. PubMed ID: 32349559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposing Metformin for Cancer Treatment: A Great Challenge of a Promising Drug.
    Saengboonmee C; Sanlung T; Wongkham S
    Anticancer Res; 2021 Dec; 41(12):5913-5918. PubMed ID: 34848445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening Medications for Association with Progression to Wet Age-Related Macular Degeneration.
    Wang SV; Kulldorff M; Poor S; Rice DS; Banks A; Li N; Lii J; Gagne JJ
    Ophthalmology; 2021 Feb; 128(2):248-255. PubMed ID: 32777229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological Advances in the Treatment of Age-related Macular Degeneration.
    Gil-Martínez M; Santos-Ramos P; Fernández-Rodríguez M; Abraldes MJ; Rodríguez-Cid MJ; Santiago-Varela M; Fernández-Ferreiro A; Gómez-Ulla F
    Curr Med Chem; 2020; 27(4):583-598. PubMed ID: 31362645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decoding Race and Age-Related Macular Degeneration: GPR 143 Activity Is the Key.
    Tung D; McKay BS
    Adv Exp Med Biol; 2023; 1415():43-47. PubMed ID: 37440012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of PGC-1α in age-related macular degeneration (AMD) - the involvement of mitochondrial quality control, autophagy, and antioxidant response.
    Hyttinen J; Blasiak J; Tavi P; Kaarniranta K
    Expert Opin Ther Targets; 2021 Sep; 25(9):773-785. PubMed ID: 34637373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutraceuticals/Drugs Promoting Mitophagy and Mitochondrial Biogenesis May Combat the Mitochondrial Dysfunction Driving Progression of Dry Age-Related Macular Degeneration.
    Lewis Luján LM; McCarty MF; Di Nicolantonio JJ; Gálvez Ruiz JC; Rosas-Burgos EC; Plascencia-Jatomea M; Iloki Assanga SB
    Nutrients; 2022 May; 14(9):. PubMed ID: 35565950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of systemic drugs on the development and progression of age-related macular degeneration.
    Grimes KR; Aloney A; Skondra D; Chhablani J
    Surv Ophthalmol; 2023; 68(3):332-346. PubMed ID: 36731638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.